BioNTech Acquires CureVac for $1.25 Billion in Share Deal
Deal Overview
German biotech firm BioNTech has announced the acquisition of its rival CureVac for approximately $1.25 billion in BioNTech shares. This move aims to...
AstraZeneca Eyes $80 Billion Goal with New Cancer Drugs
AstraZeneca (AZN) is aiming to meet its ambitious $80 billion target by 2030, with three promising cancer treatments unveiled in recent studies. The drugs...
New Covid Variant NB.1.8.1 Spreads Globally, Concerns Rise
A new COVID variant, NB.1.8.1, is gaining traction globally, including in the United States. The World Health Organization (WHO) announced that it is monitoring...
FDA Limits COVID Vaccine Access, Prioritizes High-Risk Groups
The Trump administration’s recent decision to limit approval for seasonal COVID-19 shots to seniors and those at high risk has raised concerns about accessibility...
Cat Food Recall Issued After Bird Flu Linked to Cat’s Death
Northwest Naturals is recalling a line of its raw and frozen cat food after authorities confirmed that a contaminated batch caused the death of...
Mysterious Disease Claims 143 Lives in Democratic Republic of the Congo
An unidentified disease has claimed the lives of 143 people in Kwango Province, located in southwestern Democratic Republic of the Congo (DRC), during November,...